• By ICR Secretariat
  • Posted Monday, August 5, 2019

Wellington raises €210M fund to back European biotechs


Wellington Partners has raised a €210 million ($234 million) life science fund to back biotechs in German-speaking parts of Europe and beyond. The fund sets Wellington up to invest in 15 to 20 drug development and medical device companies.